Reference Hub2
Clinical and Experimental Evidence of Cirrhosis-Related Parkinsonism

Clinical and Experimental Evidence of Cirrhosis-Related Parkinsonism

Omar El Hiba, Bilal El-Mansoury, Hicham Chatoui, Hind Benammi, Tiziano Balzano, Mohamed Merzouki, My Abdelmonaim El Hidan, Jayakumar Radhakrishnan, Lahoucine Bahi, Hamid Rguibi Idrissi, Nabila Saadaoui, Mounir Tilaoui, Tiago Fleming Outeiro, Michael D. Norenberg
ISBN13: 9781668451564|ISBN10: 1668451565|EISBN13: 9781668451571
DOI: 10.4018/978-1-6684-5156-4.ch007
Cite Chapter Cite Chapter

MLA

El Hiba, Omar, et al. "Clinical and Experimental Evidence of Cirrhosis-Related Parkinsonism." Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease, edited by Ahmed Draoui, et al., IGI Global, 2023, pp. 102-119. https://doi.org/10.4018/978-1-6684-5156-4.ch007

APA

El Hiba, O., El-Mansoury, B., Chatoui, H., Benammi, H., Balzano, T., Merzouki, M., Abdelmonaim El Hidan, M., Radhakrishnan, J., Bahi, L., Idrissi, H. R., Saadaoui, N., Tilaoui, M., Outeiro, T. F., & Norenberg, M. D. (2023). Clinical and Experimental Evidence of Cirrhosis-Related Parkinsonism. In A. Draoui, O. El Hiba, & A. Jayakumar (Eds.), Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease (pp. 102-119). IGI Global. https://doi.org/10.4018/978-1-6684-5156-4.ch007

Chicago

El Hiba, Omar, et al. "Clinical and Experimental Evidence of Cirrhosis-Related Parkinsonism." In Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease, edited by Ahmed Draoui, Omar El Hiba, and Arumugam R. Jayakumar, 102-119. Hershey, PA: IGI Global, 2023. https://doi.org/10.4018/978-1-6684-5156-4.ch007

Export Reference

Mendeley
Favorite

Abstract

The clinical significance of hepatic encephalopathy (HE) includes a variety of neuropsychiatric abnormalities arising from both chronic and acute hepatic failures. Cirrhotic patients manifest symptoms related to acquired hepatolenticular degeneration (parkinsonism in cirrhosis); the disease is characterized by extrapyramidal symptoms including hypokinesia, dystonia, and rigidity that are rapidly progressive and independent of the severity of cognitive dysfunction, while imaging techniques revealed T1-weighted hyperintense signals in the globus pallidus (GP) and substantia nigra (SN) along with manganese (Mn) deposition leading to the dysfunction of the dopaminergic, glutamatergic, as well as GABAergic neurotransmitter systems in the basal ganglia. Through the chapter, the authors emphasize the common neurological and cognitive features between Parkinson's disease/parkinsonism and HE with a special focus on the underlying pathophysiological mechanisms.
Full Text Preview

Clinical Evidence Of Chronic Parkinsonism In Advanced Liver Disease

Dering thelast century, particularly the first half,considerable attention was dedicated to the characterization of cirrhosis-related brain disorders(Stadler, 1935; Van Woerkem, 1914; Wilson, 1971)through clinico-pathological approaches of single cases or small series. While, the first establishment of the term “acquired type of chronic hepatocerebral degeneration” was elaborated by Victor et al in 1965(Victor et al., 1965), which intended to make a distinction from Wilson disease; a primarily genetic liver disease associated to copper accumulation due to the gene ATP7B mutation encoding for a transmembrane copper-transporting ATPase, which impacts several organs including the brain(Członkowska et al., 2018).Since, different aspects were defined including a wide range of neuro-cognitive disorders arising from chronic liver failure, different from those associated to acute and transient episodes of HE (Victor et al., 1965 ;Finlayson & Superville, 1981; Levy et al., 1983; Toghill et al., 1967; Weissenborn & Kolbe, 1998). Most of these symptoms refersto BG dysfunctions with abnormal involuntary movements including tremor, myoclonus, choreoathetosis, dystonia, rigidity, and dysarthria along with ataxia, pyramidal tract signs, and dementia (Jog & Lang, 1995).

References

Alonso J. Córdoba J. Rovira A. (2014). Brain magnetic resonance in hepatic encephalopathy. Seminars in Ultrasound. CT and MRI, 35(2), 136–152.24745889
Amodio P. Montagnese S. Gatta A. Morgan M. Y. (2004). Characteristics of minimal hepatic encephalopathy.Metabolic Brain Disease, 19(3/4), 253–267. 10.1023/B:MEBR.0000043975.01841.de15554421
Apetauerova D. Hildebrand P. Scala S. Zani J. W. Lipert L. Clark E. Fennell T. Gordon F. D. (2021). A prospective study of the prevalence of parkinsonism in patients with liver cirrhosis.Hepatology Communications, 5(2), 323–333. 10.1002/hep4.162433553978
Awada A. Sullivan S. Palkar V. Sbeih F. Naufal R. Al Rajeh S. (1995). Brain magnetic resonance imaging in non-alcoholic cirrhosis.European Journal of Radiology, 21(2), 84–88. 10.1016/0720-048X(95)00694-L8850497
Bergeron M. Reader T. A. Layrargues G. P. Butterworth R. F. (1989). Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.Neurochemical Research, 14(9), 853–859. 10.1007/BF009648142480534
Bergeron M. Swain M. S. Reader T. A. Butterworth R. F. (1995). Increased mesocortical dopaminergic function following ammonia administration to rats with portacaval anastomosis.Neurochemical Research, 10, 79–86. 10.1007/BF009951567739763
Brunberg J. A. Kanal E. Hirsch W. Van Thiel D. H. (1991). Chronic acquired hepatic failure: MR imaging of the brain at 1.5 T.AJNR. American Journal of Neuroradiology, 12(5), 909–914.1950920
Burkhard P. R. Delavelle J. Du Pasquier R. Spahr L. (2003a). Chronic parkinsonism associated with cirrhosis: A distinct subset of acquired hepatocerebral degeneration.Archives of Neurology, 60(4), 521–528. 10.1001/archneur.60.4.52112707065
Burkhard P. R. Delavelle J. Du Pasquier R. Spahr L. (2003b). Chronic Parkinsonism Associated With Cirrhosis.Archives of Neurology, 60(4), 521. 10.1001/archneur.60.4.52112707065
Butterworth R. F. (2000). Complications of cirrhosis III. Hepatic encephalopathy.Journal of Hepatology, 32, 171–180. 10.1016/S0168-8278(00)80424-910728803
Butterworth R. F. (2013). Parkinsonism in cirrhosis: Pathogenesis and current therapeutic options.Metabolic Brain Disease, 28(2), 261–267. 10.1007/s11011-012-9341-723086199
Butterworth R. F. (2019). Hepatic Encephalopathy in Cirrhosis : Pathology and Pathophysiology.Drugs, 0123456789(S1), 17–21. Advance online publication. 10.1007/s40265-018-1017-030706423
Cauli O. Llansola M. Erceg S. Felipo V. (2006). Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra.Journal of Hepatology, 45(5), 654–661. 10.1016/j.jhep.2006.06.01916982110
Chandra S. V. (1972). Histological and histochemical changes in experimental manganese encephalopathy in rabbits.Archiv fur Toxikologie, 29(1), 29–38. 10.1007/BF003165124261594
Chaudhuri K. R. Healy D. G. Schapira A. H. (2006). Non-motor symptoms of Parkinson’s disease: Diagnosis and management.Lancet Neurology, 5(3), 235–245. 10.1016/S1474-4422(06)70373-816488379
Chaudhuri K. R. Schapira A. H. V. (2009). Non-motor symptoms of Parkinson’s disease: Dopaminergic pathophysiology and treatment.Lancet Neurology, 8(5), 464–474. 10.1016/S1474-4422(09)70068-719375664
Chen, P., Bornhorst, J., & Aschner, M. A. (2018). Manganese metabolism in humans. Academic Press.
Couper, J. (1837). On the effects of black oxide of manganese when inhaled into the lungs. Br Ann Med Pharmacol, 1, 41–42.
Członkowska A. Litwin T. Dusek P. Ferenci P. Lutsenko S. Medici V. Rybakowski J. K. Weiss K. H. Schilsky M. L. (2018). Wilson disease.Nature Reviews. Disease Primers, 4(1), 21. 10.1038/s41572-018-0018-330190489
De Virgilio A. Greco A. Fabbrini G. Inghilleri M. Rizzo M. I. Gallo A. Conte M. Rosato C. Ciniglio Appiani M. de Vincentiis M. (2016). Parkinson’s disease: Autoimmunity and neuroinflammation.Autoimmunity Reviews, 15(10), 1005–1011. 10.1016/j.autrev.2016.07.02227497913
Duty S. Jenner P. (2011). Animal models of Parkinson’s disease: A source of novel treatments and clues to the cause of the disease.British Journal of Pharmacology, 164(4), 1357–1391. 10.1111/j.1476-5381.2011.01426.x21486284
El Hiba O. Gamrani H. Chatoui H. Ahboucha S. (2013). Loss of tyrosine hydroxylase expression within the nigro-striato-cortical pathways in the cirrhotic rat: The possible restorative effect of the neurosteroid dehydroepiandrosterone sulfate.Acta Histochemica, 115(6), 637–645. 10.1016/j.acthis.2013.01.00623453752
Emara A. M. El-Ghawabi S. H. Madkour O. I. El-Samra G. H. (1971). Chronic manganese poisoning in the dry battery industry.Occupational and Environmental Medicine, 28(1), 78–82. 10.1136/oem.28.1.785101169
Fernandez‐Rodriguez R. Contreras A. De Villoria J. G. Grandas F. (2010). Acquired hepatocerebral degeneration: Clinical characteristics and MRI findings.European Journal of Neurology, 17(12), 1463–1470. 10.1111/j.1468-1331.2010.03076.x20491897
Ferrara J. Jankovic J. (2009). Acquired hepatocerebral degeneration.Journal of Neurology, 256(3), 320–332. 10.1007/s00415-009-0144-719224314
Finlayson M. H. Superville B. (1981). Distribution of cerebral lesions in acquired hepatocerebral degeneration.Brain, 104(Pt 1), 79–95. 10.1093/brain/104.1.797470846
Fischer J. Baldessarini R. (1971). False neurotransmitters and hepatic failure.Lancet, 298(7715), 75–80. 10.1016/S0140-6736(71)92048-44103986
Hanner J. S. Li K. C. Davis G. L. (1988). Acquired hepatocerebral degeneration: MR similarity with Wilson disease.Journal of Computer Assisted Tomography, 12(6), 1076–1077. 10.1097/00004728-198811000-000363183119
Hazell A. S. Normandin L. Norenberg M. D. Kennedy G. Yi J.-H. (2006). Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment.Neuroscience Letters, 396(3), 167–171. 10.1016/j.neulet.2005.11.06416384640
Inoue E. Hori S. Narumi Y. Fujita M. Kuriyama K. Kadota T. Kuroda C. H. (1991). Portal-systemic encephalopathy: Presence of basal ganglia lesions with high signal intensity on MR images.Radiology, 179(2), 551–555. 10.1148/radiology.179.2.20143102014310
Jagmag S. A. Tripathi N. Shukla S. D. Maiti S. Khurana S. (2016). Evaluation of models of Parkinson’s disease.Frontiers in Neuroscience, 9, 503. 10.3389/fnins.2015.0050326834536
Jog M. S. Lang A. E. (1995). Chronic acquired hepatocerebral degeneration: Case reports and new insights.Movement Disorders, 10(6), 714–722. 10.1002/mds.8701006048749990
Kim J. Kim J.-M. Kim Y. K. Shin J. W. Choi S. H. Kim S. E. Kim Y. (2007). Dopamine transporter SPECT of a liver cirrhotic with atypical parkinsonism.Industrial Health, 45(3), 497–500. 10.2486/indhealth.45.49717634700
Kreis R. Ross B. D. Farrow N. A. Ackerman Z. (1992). Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy.Radiology, 182(1), 19–27. 10.1148/radiology.182.1.13457601345760
Krieger D. Krieger S. Theilmann L. Jansen O. Gass P. Lichtnecker H. (1995). Manganese and chronic hepatic encephalopathy.Lancet, 346(8970), 270–274. 10.1016/S0140-6736(95)92164-87630246
Krieger S. Jauß M. Jansen O. Stiehl A. Sauer P. Geißler M. Theilmann L. Krieger D. (1997). MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: Results of a controlled prospective clinical investigation.Journal of Hepatology, 27(1), 121–126. 10.1016/S0168-8278(97)80290-59252084
Krieger S. Jauss M. Jansen O. Theilmann L. Geissler M. Krieger D. (1996). Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis.Gastroenterology, 111(1), 147–155. 10.1053/gast.1996.v111.pm86981938698193
Kulisevsky J. Ruscalleda J. Grau J. M. (1991). MR imaging of acquired hepatocerebral degeneration.AJNR. American Journal of Neuroradiology, 12(3), 527.2058508
Lang A. E. Obeso J. A. (2004). Challenges in Parkinson’s disease: Restoration of the nigrostriatal dopamine system is not enough.Lancet Neurology, 3(5), 309–316. 10.1016/S1474-4422(04)00740-915099546
Layrargues G. P. (2001).. . Movement Dysfunction and Hepatic Encephalopathy., 16(June), 27–35.
Lee J. Lacomis D. Comu S. Jacobsohn J. Kanal E. (1998). Acquired hepatocerebral degeneration: MR and pathologic findings.AJNR. American Journal of Neuroradiology, 19(3), 485–487.9541303
Levy V. G. Cameron E. Ollat H. Opolon P. Darnis F. Contamin F. (1983). Chronic hepatic encephalopathies. Acquired cerebral degeneration not due to Wilson’s disease. La Semaine Des Hopitaux: Organe Fonde Par L’association D’enseignement MedicalL’Hôpital à Paris, 59(18), 1369–1373.
Lockwood A. H. Yap E. W. H. Rhoades H. M. Wong W.-H. (1991). Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy.Journal of Cerebral Blood Flow and Metabolism, 11(2), 331–336. 10.1038/jcbfm.1991.661997505
Lunzer M. James I. M. Weinman J. Sherlock S. (1974). Treatment of chronic hepatic encephalopathy with levodopa.Gut, 15(7), 555–561. 10.1136/gut.15.7.5554430473
Mehkari Z. Mohammed L. Javed M. Althwanay A. Ahsan F. Oliveri F. Goud H. K. Rutkofsky I. H. (2020). Manganese, a Likely Cause of “Parkinson’s in Cirrhosis”, a Unique Clinical Entity of Acquired Hepatocerebral Degeneration.Cureus, 12(9). Advance online publication. 10.7759/cureus.1044833072457
Methawasin K. Chonmaitree P. Wongjitrat C. Rattanamongkolgul S. Asawavichienjinda T. (2016). Movement Disorders in Non-Wilsonian Cirrhotic Patients: A Report of the Prevalence and Risk Factors from a Study Done in a Medical School in an Agricultural-Based Community.Journal of Movement Disorders, 9(1), 28–34. 10.14802/jmd.1503426648181
Miletić V. Ozretić D. Relja M. (2014). Parkinsonian syndrome and ataxia as a presenting finding of acquired hepatocerebral degeneration.Metabolic Brain Disease, 29(1), 207–209. 10.1007/s11011-013-9478-z24390157
Moore J. W. Dunk A. A. Crawford J. R. Deans H. Besson J. A. O. De Lacey G. Sinclair T. S. Mowat N. A. G. Brunt P. W. (1989). Neuropsychological deficits and morphological MRI brain scan abnormalities in apparently healthy non-encephalopathic patients with cirrhosis: A controlled study.Journal of Hepatology, 9(3), 319–325. 10.1016/0168-8278(89)90140-22691567
Morgan M. Y. Jakobovits A. W. James I. M. Sherlock S. (1980). Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy.Gastroenterology, 78(4), 663–670. 10.1016/0016-5085(80)90665-47353752
Mosher, T. J., Lacey, P. G., Barron, T. F., McNamara, K. P., & Devenyi, A. G. (1994). Increased signal intensity in the basal ganglia on T1-weighted MRI correlates with elevated erythrocyte manganese in patients with chronic liver disease. Proc. Soc. Magnetic Resonance, 1(8).
Mousseau D. D. Baker G. B. Butterworth R. F. (1997). Increased density of catalytic sites and expression of brain monoamine oxidase A in humans with hepatic encephalopathy.Journal of Neurochemistry, 68(3), 1200–1208. 10.1046/j.1471-4159.1997.68031200.x9048767
Mousseau D. D. Perney P. Layrargues G. P. Butterworth R. F. (1993). Selective loss of pallidal dopamine D2 receptor density in hepatic encephalopathy.Neuroscience Letters, 162(1–2), 192–196. 10.1016/0304-3940(93)90593-A8121627
Noone M. Pradeep Kumar V. Ummer K. Achambat L. Salam K. (2008). Cirrhosis presenting as Parkinsonism.Annals of Indian Academy of Neurology, 11(3), 179–181. 10.4103/0972-2327.4293819893665
Norenberg, M. D. (1990). Astrocytes in hepatic encephalopathy. Cirrhosis, Hepatic Encephalopathy, and Ammonium Toxicity, 81–97.
Ohl F. Arndt S. S. van der Staay F. J. (2008). Pathological anxiety in animals.Veterinary Journal (London, England), 175(1), 18–26. 10.1016/j.tvjl.2006.12.01317321766
Park H. K. Kim S. M. Choi C. G. Lee M. C. Chung S. J. (2008). Effect of trientine on manganese intoxication in a patient with acquired hepatocerebral degeneration.Movement Disorders, 23(5), 768–770. 10.1002/mds.2195718307260
Pentschew A. Ebner F. F. Kovatch R. M. (1963). Experimental manganese encephalopathy in monkeys: A preliminary report.Journal of Neuropathology and Experimental Neurology, 22(3), 488–499. 10.1097/00005072-196307000-0001014045007
Pomier-Layrargues G. Spahr L. Butterworth R. (1995). Increased manganese concentrations in pallidum of cirrhotic patients.Lancet, 345(8951), 735. 10.1016/S0140-6736(95)90909-57885158
Pujol A. Graus F. Peri J. Mercader J. M. Rimola A. (1991). Hyperintensity in the globus pallidus on T1‐weighted and inversion‐recovery MRI: A possible marker of advanced liver disease.Neurology, 41(9), 1526. 10.1212/WNL.41.9.15261891111
Pujol J. Kulisevsky J. Moreno A. Deus J. Alonso J. Balanzo J. Marti-Vilalta J. L. Capdevila A. (1996). Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy.Neurology, 47(6), 1526–1530. 10.1212/WNL.47.6.15268960739
Rose C. Butterworth R. F. Zayed J. Normandin L. Todd K. Michalak A. Spahr L. Huet P. Pomier–Layrargues G. (1999). Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.Gastroenterology, 117(3), 640–644. 10.1016/S0016-5085(99)70457-910464140
Sahney A. Sharma B. C. Jindal A. Anand L. Arora V. Vijayaraghavan R. Dhamija R. M. Kumar G. Bhardwaj A. Sarin S. K. (2019). A double-blind randomized controlled trial to assess efficacy of bromocriptine in cirrhotic patients with hepatic parkinsonism.Liver International, 39(4), 684–693. 10.1111/liv.1402430554466
Saito H. Ejima A. (1995). Liver dysfunction and probable manganese accumulation in the brainstem and basal ganglia.Journal of Neurology, Neurosurgery, and Psychiatry, 58(6), 760–761. 10.1136/jnnp.58.6.760-a7608690
Shin, H., & Park, H. K. (2017). Recent Updates on Acquired Hepatocerebral Degeneration. Tremor and Other Hyperkinetic Movements, 1–12. 10.7916/D8TB1K44
Shin H.-W. Park H. K. (2017). Recent updates on acquired hepatocerebral degeneration.Tremor and Other Hyperkinetic Movements (New York, N.Y.), 7.28975044
Spahr L. Butterworth R. F. Fontaine S. Bui L. Therrien G. Milette P. C. Lebrun L. H. Zayed J. Leblanc A. Pomier‐Layrargues G. (1996). Increased blood manganese in cirrhotic patients: Relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms.Hepatology (Baltimore, Md.), 24(5), 1116–1120. 10.1002/hep.5102405238903385
Stadler H. (1935). Histopathologische Untersuchungen zur Frage der Beziehung zwischen Leber-und Gehirnveränderungen.Zeitschrift für die Gesamte Neurologie und Psychiatrie, 154(1), 626–657. 10.1007/BF02865820
Sureka B. Bansal K. Patidar Y. Rajesh S. Mukund A. Arora A. (2015). Neurologic Manifestations of Chronic Liver Disease and Liver Cirrhosis.Current Problems in Diagnostic Radiology, 44(5), 449–461. 10.1067/j.cpradiol.2015.03.00425908229
Tarter R. Sandford S. Hays A. Van Thiel D. (1986). Cerebral morphological abnormalities associated with non-alcoholic cirrhosis.Lancet, 328(8512), 893–895. 10.1016/S0140-6736(86)90413-72876329
Taylor-Robinson S. D. Oatridge A. Hajnal J. V. Burroughs A. K. McIntyre N. deSouza N. M. (1995). MR Imaging of the basal ganglia in chronic liver disease: Correlation of T 1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status.Metabolic Brain Disease, 10(2), 175–188. 10.1007/BF019918647675015
Taylor-Robinson S. D. Sargentoni J. Marcus C. D. Morgan M. Y. Bryant D. J. (1994). Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy.Metabolic Brain Disease, 9(4), 347–359. 10.1007/BF020988817898401
Thuluvath P. J. Edwin D. Yue N. C. Devilliers C. Hochman S. Klein A. (1995). Increased signals seen in globus pallidus in Tl-weighted magnetic resonance imaging in cirrhotics are not suggestive of chronic hepatic encephalopathy.Hepatology (Baltimore, Md.), 21(2), 440–442. 10.1016/0270-9139(95)90105-17843718
Toghill P. J. Johnston A. W. Smith J. F. (1967). Choreoathetosis in porto-systemic encephalopathy.Journal of Neurology, Neurosurgery, and Psychiatry, 30(4), 358–363. 10.1136/jnnp.30.4.3586055345
Tryc A. B. Goldbecker A. Berding G. Rümke S. Afshar K. Shahrezaei G. H. Pflugrad H. Barg-Hock H. Strassburg C. P. Hecker H. Weissenborn K. (2013). Cirrhosis-related Parkinsonism: Prevalence, mechanisms and response to treatments.Journal of Hepatology, 58(4), 698–705. 10.1016/j.jhep.2012.11.04323220368
Tuschl K. Mills P. B. Clayton P. T. (2013). Manganese and the Brain. In Metal Related Neurodegenerative Disease (1st ed., Vol. 110). Elsevier Inc.10.1016/B978-0-12-410502-7.00013-2
Van Woerkem W. (1914). La cirrhose hepatique avec alterations dans les centres nerveux evoluant chez des sujets d’age moyen. Nouvelle Iconographie de La Salpetriere. Clinique Des Maladies Du Systeme Nerveux, 7, 41–45.
Victor M. Adams R. D. Cole M . (1965). The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration.Medicine, 44(5), 345–396. 10.1097/00005792-196509000-000015318075
Wang J. D. Huang C. C. Hwang Y. H. Chiang J. R. Lin J. M. Chen J. S. (1989). Manganese induced parkinsonism: An outbreak due to an unrepaired ventilation control system in a ferromanganese smelter.Occupational and Environmental Medicine, 46(12), 856–859. 10.1136/oem.46.12.8562611159
Weissenborn K. Ehrenheim C. Hori A. Kubicka S. Manns M. P. (1995). Pallidal lesions in patients with liver cirrhosis: Clinical and MRI evaluation.Metabolic Brain Disease, 10(3), 219–231. 10.1007/BF020810278830282
Weissenborn K. Kolbe H. (1998). The basal ganglia and portal-systemic encephalopathy.Metabolic Brain Disease, 13(4), 261–272. 10.1023/A:102062860724510206819
Wilson S. A. K. (1971). Progressive lenticular degeneration: A familial nervous disease associated with cirrhosis of the liver.Archives of Neurology, 25(2), 180–186. 10.1001/archneur.1971.00490020098013
Yang, H. J., Park, S. H., Seo, M., Weon, Y. C., & Kim, Y. (2018). 18 F-FP-CIT dopamine transporter PET findings in cirrhotic patients with parkinsonism. NeuroToxicology, 64(2016), 78–84. 10.1016/j.neuro.2017.02.014
Zeneroli M. L. Cioni G. Crisi G. Vezzelli C. Ventura E. (1991). Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: An MR imaging study.Magnetic Resonance Imaging, 9(3), 295–302. 10.1016/0730-725X(91)90414-H1881246

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.

Texte d'origine
Évaluez cette traduction
Votre avis nous aidera à améliorer Google Traduction